Inhibition of Rauscher leukemia virus and avian myeloblastosis virus DNA polymerases by tilorone (NSC-143969) and its analogs.

M. Schafer,M. Chirigos,T. Papas

1974-11-01

Abstract:

What problem does this paper attempt to address?

Discovery of (R)-5-((5-(1-methyl-1h-pyrazol-4-yl)-4-(methylamino)pyrimidin-2-yl)amino)-3-(piperidin-3-yloxy)picolinonitrile, a Novel CHK1 Inhibitor for Hematologic Malignancies.

Lexian Tong,Pinrao Song,Kailong Jiang,Lei Xu,Tingting Jin,Peipei Wang,Xiaobei Hu,Sui Fang,Anhui Gao,Yubo Zhou,Tao Liu,Jia Li,Yongzhou Hu

DOI: https://doi.org/10.1016/j.ejmech.2019.03.062

IF: 7.088

2019-01-01

European Journal of Medicinal Chemistry

Abstract:Through virtual screening, we identified the lead compound MCL1020, which exhibited modest CHK1 inhibitory activity. Then a series of 5-(pyrimidin-2-ylamino)picolinonitrile derivatives as CHK1 inhibitors were discovered by further rational optimization. One promising molecule. (R)-17, whose potency was one of the best, had an IC50 of 0.4 nM with remarkable selectivity (>4300-fold CHK1 vs. CHK2). Compound (R)-17 effectively inhibited the growth of malignant hematopathy cell lines especially Z-138 (IC50: 0.013 mu M) and displayed low affinity for hERG (IC50> 40 mu M). Moreover, (R)-17 significantly suppressed the tumor growth in Z-138 cell inoculated xenograft model (20 mg/kg I.V., TGI = 90.29%) as a single agent with body weight unaffected. Taken together, our data demonstrated compound (R)-17 could be a promising drug candidate for the treatment of hematologic malignancies. (C) 2019 Published by Elsevier Masson SAS.
Mechanism and spectrum of inhibition of a 4’-cyano modified nucleotide analog against diverse RNA polymerases of prototypic respiratory RNA viruses

Calvin J. Gordon,Simon M. Walker,Egor P. Tchesnokov,Dana Kocincova,Jared Pitts,Dustin S. Siegel,Jason K. Perry,Joy Y. Feng,John P. Bilello,Matthias Götte

DOI: https://doi.org/10.1101/2024.04.22.590607

2024-04-23

Abstract:The development of safe and effective broad-spectrum antivirals that target the replication machinery of respiratory viruses is of high priority in pandemic preparedness programs. Here, we studied the mechanism of action of a newly discovered nucleotide analog against diverse RNA-dependent RNA polymerases (RdRp) of prototypic respiratory viruses. GS-646939 is the active 5′-triphosphate (TP) metabolite of a 4ʹ-cyano modified -adenosine analog phosphoramidate prodrug GS-7682. Enzyme kinetics show that the RdRps of human rhinovirus type 16 (HRV-16) and enterovirus 71 (EV-71) incorporate GS-646939 with unprecedented selectivity; GS-646939 is incorporated 20-50-fold more efficiently than its natural ATP counterpart. The RdRp complex of respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) incorporate GS-646939 and ATP with similar efficiency. In contrast, influenza B RdRp shows a clear preference for ATP and human mitochondrial RNA polymerase (h-mtRNAP) does not show significant incorporation of GS-646939. Once incorporated into the nascent RNA strand, GS-646939 acts as a chain-terminator although higher NTP concentrations can partially overcome inhibition for some polymerases. Modeling and biochemical data suggest that the 4ʹ-modification inhibits RdRp translocation. Comparative studies with GS-443902, the active triphosphate form of the 1′-cyano modified prodrugs remdesivir and obeldesivir, reveal not only different mechanisms of inhibition, but also differences in the spectrum of inhibition of viral polymerases. In conclusion, 1ʹ-cyano and 4ʹ-cyano modifications of nucleotide analogs provide complementary strategies to target the polymerase of several families of respiratory RNA viruses.

Biochemistry
Novel analogues of a nonnucleoside SARS-CoV-2 RdRp inhibitor as potential antivirotics

Luca Julianna Tóth,Kateřina Krejčová,Milan Dejmek,Eva Žilecká,Blanka Klepetářová,Lenka Poštová Slavětínská,Evžen Bouřa,Radim Nencka

DOI: https://doi.org/10.3762/bjoc.20.91

2024-05-07

Beilstein Journal of Organic Chemistry

Abstract:The RNA-dependent RNA polymerase (RdRp) represents a prominent target in the discovery and development of new antivirotics against RNA viruses, inhibiting the replication process. One of the most targeted RNA viruses of the last years is, without doubt, SARS-CoV-2, the cause of the recent COVID-19 pandemic. HeE1-2Tyr, a known inhibitor of flaviviral RdRp, has been discovered to also have antiviral potency against this coronavirus. In this study, we report three distinct modifications of HeE1-2Tyr: conversion of the core from a benzothiazole to a benzoxazole moiety and two different scaffold simplifications, respectively. We provide a novel synthetic approach and, in addition, evaluate the final molecules in an in vitro polymerase assay for biological activity. Beilstein J. Org. Chem. 2024, 20, 1029–1036. doi:10.3762/bjoc.20.91

chemistry, organic
Design, Synthesis, and Biological Evaluation of a Novel Series of Teriflunomide Derivatives as Potent Human Dihydroorotate Dehydrogenase Inhibitors for Malignancy Treatment

Chungen Li,Xiaowei Yang,Yuan Luo,Huan Liu,Xi Zhong,Xia Zhou,Ting Zeng,Lei Tao,Yue Zhou,Kun Gou,Xinyu Yang,Xiaocong Liu,Qiang Chen,Yinglan Zhao,Youfu Luo

DOI: https://doi.org/10.1021/acs.jmedchem.1c01711

IF: 8.039

2021-12-14

Journal of Medicinal Chemistry

Abstract:Human dihydroorotate dehydrogenase (hDHODH), as the fourth and rate-limiting enzyme of the de novo pyrimidine synthesis pathway, is regarded as an attractive target for malignancy therapy. In the present study, a novel series of teriflunomide derivatives were designed, synthesized, and evaluated as hDHODH inhibitors. 13t was the optimal compound with promising enzymatic activity (IC50 = 16.0 nM), potent antiproliferative activity against human lymphoma Raji cells (IC50 = 7.7 nM), and excellent aqueous solubility (20.1 mg/mL). Mechanistically, 13t directly inhibited hDHODH and induced cell cycle S-phase arrest in Raji cells. The acute toxicity assay indicated a favorable safety profile of 13t. Notably, 13t displayed significant tumor growth inhibition activity with a tumor growth inhibition (TGI) rate of 81.4% at 30 mg/kg in a Raji xenograft model. Together, 13t is a promising inhibitor of hDHODH and a preclinical candidate for antitumor therapy, especially for lymphoma.

chemistry, medicinal
The effects of gastric surgery on systemic ghrelin levels in the morbidly obese.

E. Lin,N. Gletsu,Kim Fugate,D. McClusky,L. Gu,Juan-li Zhu,B. Ramshaw,D. Papanicolaou,T. Ziegler,C. D. Smith

DOI: https://doi.org/10.1001/ARCHSURG.139.7.780

2004-07-01

Archives of Surgery

Abstract:HYPOTHESIS Circulating ghrelin, produced primarily in the stomach, is a powerful orexigen. Ghrelin levels are elevated in states of hunger, but rapidly decline postprandially. Early alterations in ghrelin levels in morbidly obese patients undergoing weight reduction surgery may be attributed to gastric partitioning. DESIGN AND PATIENTS Thirty-four patients underwent Roux-en-Y gastric bypass with a completely divided gastroplasty to create a 15-mL vertically oriented gastric pouch. Eight other patients underwent other gastric procedures that did not involve complete division of the stomach, including 4 vertical banded gastroplasties and 4 antireflux surgical procedures. Six additional patients undergoing antireflux surgery served as lean control subjects. Plasma samples were obtained before surgery and immediately after surgery. In a substudy, plasma was collected after Roux-en-Y limb formation and after dividing the stomach to identify any changes in plasma ghrelin levels. SETTING Tertiary university medical center. MAIN OUTCOME MEASURES Ghrelin levels at different stages of surgical intervention. RESULTS Mean +/- SEM preoperative and postoperative ghrelin levels in the gastric bypass group were 355 +/- 20 and 246 +/- 13 pg/mL, respectively (P<.001). In the vertical banded gastroplasty group and in all patients undergoing antireflux surgery, ghrelin levels were not significantly changed. CONCLUSIONS Compared with morbidly obese humans, lean controls had significantly higher plasma ghrelin levels at baseline. A divided gastroplasty creating a small proximal gastric pouch results in significant early declines in circulating ghrelin levels that are not observed with other gastric procedures. This may explain, in part, the loss of hunger sensation and rapid weight loss observed following gastric bypass surgery.
The Design and Synthesis of N-1-Alkylated-5-Aminoaryalkylsubstituted-6-Methyluracils As Potential Non-Nucleoside Hiv-1 Rt Inhibitors

Xiao Lu,Yanli Chen,Ying Guo,Zhenming Liu,Yawei Shi,Yang Xu,Xiaowei Wang,Zhili Zhang,Junyi Liu

DOI: https://doi.org/10.1016/j.bmc.2007.07.058

IF: 3.461

2007-01-01

Bioorganic & Medicinal Chemistry

Abstract:Novel compounds 1a-u, which can be considered as hybrid analogues of MKC-442 and pyridinon, have been synthesized and evaluated as inhibitors of HIV-1 reverse transcriptase (HIV-1 RT). Starting from 6-methyluracil 2, 1-alkylated-5-bromomethyl-6-methyluracils 8 was prepared in four steps by hydroxymethylation, etherification, N-1 alkylation, and bromination. Finally, compounds 1a-u were achieved in the displacement of 5-bromomethyl group by nucleophiles with amino compounds. Some of compounds 1a-u showed potent inhibitory activity against HIV-1 RT. The most active compounds showed activity in the low micromolecular range with IC(50) values (IC(50) 0.82-5.09 microM) comparable to that of nevirapine (IC(50) 10.60 microM). The biological testing results are in accordance with the docking.
Design, Synthesis, Biochemical, and Antiviral Evaluations of C6 Benzyl and C6 Biarylmethyl Substituted 2-Hydroxylisoquinoline-1,3-diones: Dual Inhibition against HIV Reverse Transcriptase-Associated RNase H and Polymerase with Antiviral Activities

Sanjeev Kumar V. Vernekar,Zheng Liu,Eva Nagy,Lena Miller,Karen A. Kirby,Daniel J. Wilson,Jayakanth Kankanala,Stefan G. Sarafianos,Michael A. Parniak,Zhengqiang Wang

DOI: https://doi.org/10.1021/jm501132s

IF: 8.039

2014-12-30

Journal of Medicinal Chemistry

Abstract:Reverse transcriptase (RT) associated ribonuclease H (RNase H) remains the only virally encoded enzymatic function not targeted by current chemotherapy against human immunodeficiency virus (HIV). Although numerous chemotypes have been reported to inhibit HIV RNase H biochemically, few show significant antiviral activity against HIV. We report herein the design, synthesis, and biological evaluations of a novel variant of 2-hydroxyisoquinoline-1,3-dione (HID) scaffold featuring a crucial C-6 benzyl or biarylmethyl moiety. The synthesis involved a recently reported metal-free direct benzylation between tosylhydrazone and boronic acid, which allowed the generation of structural diversity for the hydrophobic aromatic region. Biochemical studies showed that the C-6 benzyl and biarylmethyl HID analogues, previously unknown chemotypes, consistently inhibited HIV RT-associated RNase H and polymerase with IC50s in low to submicromolar range. The observed dual inhibitory activity remained uncompromised against RT mutants resistant to non-nucleoside RT inhibitors (NNRTIs), suggesting the involvement of binding site(s) other than the NNRTI binding pocket. Intriguingly, these same compounds inhibited the polymerase, but not the RNase H function of Moloney Murine Leukemia Virus (MoMLV) RT and also inhibited Escherichia coli RNase H. Additional biochemical testing revealed a substantially reduced level of inhibition against HIV integrase. Molecular docking corroborates favorable binding of these analogues to the active site of HIV RNase H. Finally, a number of these analogues also demonstrated antiviral activity at low micromolar concentrations.

chemistry, medicinal
Identification of novel inhibitors of the transcriptional coactivator MRTF-A for HCC therapy

Miriam Jasmin Franz,Pia Wenisch,Petra Wohlleben,Laura Rupprecht,Vladimir Chubanov,Thomas Gudermann,Salla Kyheröinen,Maria Kristina Vartiainen,Markus R Heinrich,Susanne Muehlich

DOI: https://doi.org/10.1016/j.omton.2024.200855

2024-08-06

Abstract:Myocardin-related transcription factor A (MRTF-A) is a coactivator of serum response factor (SRF), which regulates the expression of genes involved in cell proliferation, migration, and differentiation and has been implicated in hepatocellular carcinoma (HCC) progression. We recently established inhibition of the transcriptional activity of MRTF-A by NS8593 as a novel therapeutic approach for HCC therapy. NS8593 is a negative gating modulator of the transient receptor potential cation channel TRPM7. In this report, we identify an aminobenzimidazole that is highly potent in inhibiting TRPM7 and its interaction with RhoA, leading to decreased SRF transcriptional activity and enhanced nuclear export of MRTF-A, as determined by fluorescence loss in photobleaching (FLIP). This resulted in reduced expression of the MRTF/SRF target genes transforming growth factor β1 (TGF-β1) and tetraspanin 5 (TSPAN5), senescence induction, and growth arrest in HCC cells. Replacement of the tetraline core by a 3-aminophenyl substructure yielded inhibitor 10 with higher potency than inhibitor 5, and further structural modifications yielded highly potent inhibitors of SRF activity, 14 and 16. Both compounds were capable of inhibiting cell proliferation and inducing senescence in HCC cells with improved efficacy compared to NS8593. These inhibitors represent valuable tools for understanding the molecular basis of drug development targeting TRPM7 and MRTFs.
Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability

John T Randolph,A Chris Krueger,Pamela L Donner,John K Pratt,Dachun Liu,Christopher E Motter,Todd W Rockway,Michael D Tufano,Rolf Wagner,Hock B Lim,Jill M Beyer,Rubina Mondal,Neeta S Panchal,Lynn Colletti,Yaya Liu,Gennadiy Koev,Warren M Kati,Lisa E Hernandez,David W A Beno,Kenton L Longenecker,Kent D Stewart,Emily O Dumas,Akhteruzzaman Molla,Clarence J Maring

DOI: https://doi.org/10.1021/acs.jmedchem.7b01630

2018-02-08

Abstract:ABT-072 is a non-nucleoside HCV NS5B polymerase inhibitor that was discovered as part of a program to identify new direct-acting antivirals (DAAs) for the treatment of HCV infection. This compound was identified during a medicinal chemistry effort to improve on an original lead, inhibitor 1, which we described in a previous publication. Replacement of the amide linkage in 1 with a trans-olefin resulted in improved compound permeability and solubility and provided much better pharmacokinetic properties in preclinical species. Replacement of the dihydrouracil in 1 with an N-linked uracil provided better potency in the genotype 1 replicon assay. Results from phase 1 clinical studies supported once-daily oral dosing with ABT-072 in HCV infected patients. A phase 2 clinical study that combined ABT-072 with the HCV protease inhibitor ABT-450 provided a sustained virologic response at 24 weeks after dosing (SVR24) in 10 of 11 patients who received treatment.
Synthesis and antiproliferative activity of a tetrahydrofuran analog of FR901464

Ivanna Pohorilets,Jacob P Beard,Julia L Driscoll,John C Schmitz,Kazunori Koide,Jacob P. Beard,Julia L. Driscoll,John C. Schmitz

DOI: https://doi.org/10.1016/j.bmcl.2024.129739

IF: 2.94

2024-04-10

Bioorganic & Medicinal Chemistry Letters

Abstract:FR901464 is a natural product that exhibits antiproliferative activity at single-digit nanomolar concentrations in cancer cells. Its tetrahydropyran-spiroepoxide covalently binds the spliceosome. Through our medicinal chemistry campaign, we serendipitously discovered that a bromoetherification formed a tetrahydrofuran. The tetrahydrofuran analog was three orders of magnitude less potent than the corresponding tetrahydropyran analogs. This study shows the significance of the tetrahydropyran ring that presents the epoxide toward the spliceosome.

chemistry, medicinal, organic
Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5‐HT)2A and DA D2 antagonism and 5‐HT1A partial agonism

Mei Huang,J. Panos,Sunoh Kwon,Y. Oyamada,L. Rajagopal,H. Meltzer

DOI: https://doi.org/10.1111/jnc.12512

2014-03-01

Journal of Neurochemistry

Abstract:Atypical antipsychotic drugs (AAPDs) have been suggested to be more effective in improving cognitive impairment in schizophrenia than typical APDs, a conclusion supported by differences in receptor affinities and neurotransmitter efflux in the cortex and the hippocampus. More potent serotonin (5‐HT)2A than dopamine (DA) D2 receptors antagonism, and direct or indirect 5‐HT1A agonism, characterize almost all AAPDs. Blonanserin, an AAPD, has slightly greater affinity for D2 than 5‐HT2A receptors. Using microdialysis and ultra performance liquid chromatography‐mass spectrometry/mass spectrometry, we compared the abilities of the typical APD, haloperidol, three AAPDs, blonanserin, lurasidone, and olanzapine, and a selective 5‐HT1A partial agonist, tandospirone, and all, except haloperidol, were found to ameliorate the cognitive deficits produced by the N‐methyl‐d‐aspartate antagonist, phencyclidine, altering the efflux of neurotransmitters and metabolites in the rat cortex and nucleus accumbens. Blonanserin, lurasidone, olanzapine, and tandospirone, but not haloperidol, increased the efflux of cortical DA and its metabolites, homovanillic acid and 3,4‐dihydroxyphenylacetic acid. Olanzapine and lurasidone increased the efflux of acetylcholine; lurasidone increased glutamate as well. None of the compounds significantly altered the efflux of 5‐HT or its metabolite, 5‐hydroxyindole acetic acid, or GABA, serine, and glycine. The ability to increase cortical DA efflux was the only shared effect of the compounds which ameliorates the deficit in cognition in rodents following phencyclidine.
International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas

A. Vizcaino,V. Moreno,F. Bosch,N. Muñoz,Xoán M. Barros‐Dios,D. M. Parkin

DOI: https://doi.org/10.1002/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U

1998-02-09

International Journal of Cancer

Abstract:Time trends in the incidence of cervical adenocarcinoma and adenosquamous cell carcinomas during the period 1973–1991 were examined using data provided by 60 population‐based cancer registries from 32 defined populations in 25 countries. Three components of the incidence trend were studied: age, calendar period of diagnosis and birth cohort. Cumulative incidence rates per 1,000 for 2 groups with age ranges 25–49 and 50–74 years were calculated from the model that best described the incidence data. There was a significant increase in the cumulative incidence of cervical adenocarcinomas in women born in the mid‐1930s and in successive cohorts thereafter in some populations in the United States (whites and Hispanic women), Australia, New Zealand (non‐Maori), England, Scotland, Denmark, Slovenia, Slovakia and Japan (Osaka) and among Chinese women in Singapore, with a general decline in the incidence in women born in earlier periods. In Sweden and Slovenia there is a suggestion of an increasing trend in both age groups. A decrease in incidence in both age groups was apparent in Finland, France and Italy. There were no changes in incidence in 24 registries covering other European, Asian and black populations in the United States. Part of the increase may be attributable to an increasing prevalence of human papillomavirus infection, and part to improvements in screening. Int. J. Cancer 75:536–545, 1998.© 1998 Wiley‐Liss, Inc.
Image-based age-group classification design using facial features

Yi-Wen Chen,M. Han,K. Song,Y. Ho

DOI: https://doi.org/10.1109/ICSSE.2010.5551744

2010-07-01

Abstract:Image recognition of a user plays an important role in designing intelligent and interactive behaviors for a domestic or service robot. In this paper, an image-based age-group classification method is proposed to estimate three levels of age groups, namely child, adult and the elderly. After face detection from the acquired image frame, human facial area is extracted and 52 feature points are located by using Lucas-Kanade image alignment method. These feature points and corresponding located facial area are used to build an active appearance model (AAM). After facial image warping, the texture features are sent to a support vector machine (SVM) to estimate the level of age group. In the experimental results, the average recognition rate of the proposed method is 87%. It will improve the interaction capability of robot in a friendly manner.
Lack of a 5' non-coding region in Tn1721 encoded tetR mRNA is associated with a low efficiency of translation and a short half-life in Escherichia coli.

R. Baumeister,P. Flache,O. Melefors,A. von Gabain,W. Hillen

DOI: https://doi.org/10.1093/NAR/19.17.4595

IF: 14.9

1991-09-11

Nucleic Acids Research

Abstract:The repressor-encoding tetR gene from Tn1721 is expressed with a very low efficiency. Its mRNA lacks an untranslated leader sequence. We have constructed protein fusions with the lacZ gene which contain between 14 and 157 5' nucleotides from the tetR gene. Since they are all expressed with similar efficiencies we conclude that the sequence information for initiation of translation is contained within the first 14 bases of the tetR coding region. These fusion transcripts are about 20-fold less efficiently translated than the wild type lacZ transcript. A toeprint analysis confirms that the initiation complex is indistinguishable from those formed by regular transcripts with 5' untranslated regions but occurs in a very low amount in vitro. Thus, the absence of a 5' leader causes a poor rate of translation initiation. The half-lives of tetR and tetR-lacZ mRNAs are about 30 seconds, which is 3-times lower than that of the wt lacZ mRNA. Inactivation of the ams/rne locus in E. coli stabilizes the tetR transcript more than ten-fold. The influence of translation on the tetR half-life is discussed.
Synthesis and Biological Evaluation of Novel 1-Aryl-5-iodo-6-benzyluracils As Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

Wei Wang,Li,Chang Liu,Liang Zhang,Han Yan,Zhi-Li Zhang,Xiao-Wei Wang,Jun-Yi Liu

DOI: https://doi.org/10.5246/jcps.2010.04.044

2010-01-01

Abstract:We have synthesized the novel compounds la-li,which are a series of hybrid analogues to 6-benzyl-1-(benzyloxymethyl)-5-iodouracil,a compound showing strong activity against HIV-1.We also evaluated the activity of these compounds as the inhibitors of HIV-1 reverse transcriptase(HIV-1 RT),and they have demonstrated moderate activity.
Design and Biological Evaluation of Novel Triaryl Pyrazoline Derivatives with Dioxane Moiety for Selective BRAFV600E Inhibition.

Hong-Lin Li,Mi-Mi Su,Yun-Jie Xu,Chen Xu,Yu-Shun Yang,Hai-Liang Zhu

DOI: https://doi.org/10.1016/j.ejmech.2018.06.043

IF: 7.088

2018-01-01

European Journal of Medicinal Chemistry

Abstract:A series of novel selective BRAFV600E inhibitory agents (Compound 1-16) 5-(2,3-dihydrobenzo[b][1,4]dioxane-6-yl)-N,3-diaryl-4,5-dihydro-1H-pyrazole-1-carbothioamides have been designed and synthesized. Their anti-proliferation and BRAF inhibitory activities were evaluated. Though 15, 4 and 12 all displayed comparable activity with the positive control Vemurafenib, only 12 indicated fine selectivity on BRAFV600E (IC50 = 0.06 μM for BRAFV600E; GI50 = 0.52 μM for A375) over BRAFWT at both kinase and cell levels. This result satisfied the designing concept of improving activity and introducing selectivity. Flow cytometry analysis and western blot convinced the apoptosis induction and kinase inhibitory activity. Docking simulation inferred the differences in binding patterns of BRAFV600E and BRAFWT, pointing out that the future orientation might be seeking for outer space binding of BRAFV600E and avoiding interactions with HIS573 of BRAFWT. These results brought potent BRAF inhibitors one step further to selective agents, enhancing the potential for safe medication.
The effects of coadministration of tilorone dihydrochloride and culture supernatants from Lactobacillus reuteri on the mouse hepatoma cell line

Mahsa Alem,Amir Ali Shahbazfar,Payman Zare,Hossein Tayefi-Nasrabadi

DOI: https://doi.org/10.4103/jcrt.JCRT_41_17

Abstract:Context: Tilorone dihydrochloride is a therapeutic agent with a different mechanism in cancer. The species of Lactobacillus have an important role in cytotoxic effect. Aims: Because of unknown effects of tilorone and culture supernatants from Lactobacillus reuteri on hepatoma, the aim of this study is to evaluate apoptotic, cytotoxic, and therapeutic effects of tilorone on mouse hepatoma cell line with and without culture supernatants from L. reuteri. Materials and methods: To do so, after cell line culture, cells were divided into different groups such as negative control, treatment with four doses of tilorone, positive control of supernatant (single dose), and combination therapy groups of different doses of tilorone with supernatant (constant doses), for 48 h. All groups were studied with pathologic tests, biochemical study, tetrazolium dye (3-(4, 5- dimethylthiazol -2-yl)-2, 5-diphenyltetrazolium bromide [MTT]) assay, and absolute real-time-polymerase chain reaction (RT-PCR) were done to assess Bax and Bcl-2 genes expression, as molecular studies. Results: MTT assay results revealed that the tilorone tissue culture IC50 (TCIC50) on the Hepa1-6 cell line was 50 μg/ml. RT-PCR analysis showed that tilorone dihydrochloride induced upregulation and downregulation in expression of Bax and Bcl-2, respectively. Simultaneous, antioxidant effect has also seen in a way that prevented necrosis, in biochemical analysis. These results were dose dependent and statistically significant compared to the control group. Conclusions: Based on these results, it appeared that this agent could be a good candidate for further evaluation as effective chemotherapy acting through the induction of apoptosis in hepatoma. The cell death caused through bacterial supernatant was rather necrosis than apoptosis.
Modification, Biological Evaluation and 3D QSAR Studies of Novel 2-(1,3-diaryl- 4,5-Dihydro-1h-pyrazol-5-yl)phenol Derivatives As Inhibitors of B-Raf Kinase.

Yu-Shun Yang,Fei Zhang,Dan-Jie Tang,Yong-Hua Yang,Hai-Liang Zhu

DOI: https://doi.org/10.1371/journal.pone.0095702

IF: 3.7

2014-01-01

PLoS ONE

Abstract:A series of novel 2-(1,3-diaryl- 4,5-dihydro-1H-pyrazol-5-yl)phenol derivatives (C1-C24) have been synthesized. The B-Raf inhibitory activity and anti-proliferation activity of these compounds have been tested. Compound C6 displayed the most potent biological activity against B-RafV600E (IC50 = 0.15 µM) and WM266.4 human melanoma cell line (GI50 = 1.75 µM), being comparable with the positive control (Vemurafenib and Erlotinib) and more potent than our previous best compounds. The docking simulation was performed to analyze the probable binding models and poses while the QSAR model was built to check the previous work as well as to introduce new directions. This work aimed at seeking more potent inhibitors as well as discussing some previous findings. As a result, the introduction of ortho-hydroxyl group on 4,5-dihydro-1H-pyrazole skeleton did reinforce the anti-tumor activity while enlarging the group on N-1 of pyrazoline was also helpful.
Population genetic characterisation of dominant Cryptosporidium parvum subtype IIaA15G2R1.

Yaoyu Feng,Eucaris Torres,Na Li,Lin Wang,D. Bowman,Lihua Xiao

DOI: https://doi.org/10.1016/j.ijpara.2013.09.002

2013-12-01

Abstract:
Novel 1,3,4-Oxadiazole Thioether Derivatives Targeting Thymidylate Synthase As Dual Anticancer/antimicrobial Agents.

Qian-Ru Du,Dong-Dong Li,Ya-Zhou Pi,Jing-Ran Li,Jian Sun,Fei Fang,Wei-Qing Zhong,Hai-Bin Gong,Hai-Liang Zhu

DOI: https://doi.org/10.1016/j.bmc.2013.02.008

IF: 3.461

2013-01-01

Bioorganic & Medicinal Chemistry

Abstract:A series of novel 1,3,4-oxadiazole thioether derivatives (compounds 9-44) were designed and synthesized as potential inhibitors of thymidylate synthase (TS) and as anticancer agents. The in vitro anticancer activities of these compounds were evaluated against three cancer cell lines by the MTT method. Among all the designed compounds, compound 18 bearing a nitro substituent exhibited more potent in vitro anticancer activities with IC50 values of 0.7±0.2, 30.0±1.2, 18.3±1.4 μM, respectively, which was superior to the positive control. In the further study, it was identified as the most potent inhibitor against two kinds of TS protein (for human TS and Escherichia coli TS, IC50 values: 0.62 and 0.47 μM, respectively) in the TS inhibition assay in vitro and the most potent antibacterial agents with MIC (minimum inhibitory concentrations) of 1.56-3.13 μg/mL against the tested four bacterial strains. Molecular docking and 3D-QSAR study supported that compound 18 can be selected as dual antitumor/antibacterial candidate in the future study.

Inhibition of Rauscher leukemia virus and avian myeloblastosis virus DNA polymerases by tilorone (NSC-143969) and its analogs.

Discovery of (R)-5-((5-(1-methyl-1h-pyrazol-4-yl)-4-(methylamino)pyrimidin-2-yl)amino)-3-(piperidin-3-yloxy)picolinonitrile, a Novel CHK1 Inhibitor for Hematologic Malignancies.

Mechanism and spectrum of inhibition of a 4’-cyano modified nucleotide analog against diverse RNA polymerases of prototypic respiratory RNA viruses

Novel analogues of a nonnucleoside SARS-CoV-2 RdRp inhibitor as potential antivirotics

Design, Synthesis, and Biological Evaluation of a Novel Series of Teriflunomide Derivatives as Potent Human Dihydroorotate Dehydrogenase Inhibitors for Malignancy Treatment

The effects of gastric surgery on systemic ghrelin levels in the morbidly obese.

The Design and Synthesis of N-1-Alkylated-5-Aminoaryalkylsubstituted-6-Methyluracils As Potential Non-Nucleoside Hiv-1 Rt Inhibitors

Design, Synthesis, Biochemical, and Antiviral Evaluations of C6 Benzyl and C6 Biarylmethyl Substituted 2-Hydroxylisoquinoline-1,3-diones: Dual Inhibition against HIV Reverse Transcriptase-Associated RNase H and Polymerase with Antiviral Activities

Identification of novel inhibitors of the transcriptional coactivator MRTF-A for HCC therapy

Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability

Synthesis and antiproliferative activity of a tetrahydrofuran analog of FR901464

Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5‐HT)2A and DA D2 antagonism and 5‐HT1A partial agonism

International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas

Image-based age-group classification design using facial features

Lack of a 5' non-coding region in Tn1721 encoded tetR mRNA is associated with a low efficiency of translation and a short half-life in Escherichia coli.

Synthesis and Biological Evaluation of Novel 1-Aryl-5-iodo-6-benzyluracils As Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

Design and Biological Evaluation of Novel Triaryl Pyrazoline Derivatives with Dioxane Moiety for Selective BRAFV600E Inhibition.

The effects of coadministration of tilorone dihydrochloride and culture supernatants from Lactobacillus reuteri on the mouse hepatoma cell line

Modification, Biological Evaluation and 3D QSAR Studies of Novel 2-(1,3-diaryl- 4,5-Dihydro-1h-pyrazol-5-yl)phenol Derivatives As Inhibitors of B-Raf Kinase.

Population genetic characterisation of dominant Cryptosporidium parvum subtype IIaA15G2R1.

Novel 1,3,4-Oxadiazole Thioether Derivatives Targeting Thymidylate Synthase As Dual Anticancer/antimicrobial Agents.